For: | Sotelo MJ, Luis García J, Torres-Mattos C, Milián H, Carracedo C, González-Ruiz MÁ, Mielgo-Rubio X, Trujillo-Reyes JC, Couñago F. Recent advances and new insights in the management of early-stage epidermal growth factor receptor-mutated non-small-cell lung cancer. World J Clin Oncol 2021; 12(10): 912-925 [PMID: 34733613 DOI: 10.5306/wjco.v12.i10.912] |
---|---|
URL: | https://www.wjgnet.com/2218-4333/full/v12/i10/912.htm |
Number | Citing Articles |
1 |
Jingjing Ding, Jun Zhou, Xiaoyi Shen, Min Zhang, Xianzhen Feng, Zhongqing Xu. Systematic analysis of the prognostic and immunological role of DHX33 in pan‐cancer. Environmental Toxicology 2023; 38(8): 2011 doi: 10.1002/tox.23827
|
2 |
Yue Zhang, Hao Wang, Ying Liu, Jing Yang, Xiaoxiao Zuo, Meilian Dong, Zhigang Zhang, Yonggang Shi, Xubin Deng, Yaoyong Lv. Comprehensive analysis of DTYMK in pan-cancer and verification in lung adenocarcinoma. Bioscience Reports 2022; 42(10) doi: 10.1042/BSR20221170
|
3 |
Linlin Zhang, Shasha Guan, Fanlu Meng, Lin Teng, Diansheng Zhong. Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1035808
|
4 |
Ying-Yi Chen, Kuan-Hsun Lin, Yen-Shou Kuo, Yuan-Ming Tsai, Hsu-Kai Huang, Tsai-Wang Huang. Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma. World Journal of Surgical Oncology 2023; 21(1) doi: 10.1186/s12957-023-03203-6
|